613 related articles for article (PubMed ID: 9790335)
21. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer.
Kim JP; Lee JH; Kim SJ; Yu HJ; Yang HK
Gastric Cancer; 1998 Mar; 1(2):125-133. PubMed ID: 11957056
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in gastric carcinoma after R0 resection with DII lymph node dissection. Tunisian experience.
Ayadi S; Daghfous A; Makni A; Fteriche F; Maghrebi H; Rebai W; Bedioui H; Chebbi F; Ksantini R; Ammous A; Jouini M; Kacem M; Ben Safta Z
Tunis Med; 2012 Nov; 90(11):812-5. PubMed ID: 23197061
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors of gastric neoplasms: experience with 1,074 cases undergoing surgical treatment at a single center].
Orsenigo E; Carlucci M; Braga M; Tomajer V; Di Palo S; Tamburini A; Di Carlo V; Staudacher C
Suppl Tumori; 2005; 4(3):S86-7. PubMed ID: 16437921
[TBL] [Abstract][Full Text] [Related]
24. Lymphadenectomy in gastric cancer: influence on prognosis of lymph node count.
Giuliani A; Caporale A; Corona M; Di Bari M; Demoro M; Ricciardulli T; Gozzo P; Galati G; Tocchi A
J Exp Clin Cancer Res; 2004 Jun; 23(2):215-24. PubMed ID: 15354405
[TBL] [Abstract][Full Text] [Related]
25. Extracapsular lymph node spread: a new prognostic factor in gastric cancer.
Alakus H; Hölscher AH; Grass G; Hartmann E; Schulte C; Drebber U; Baldus SE; Bollschweiler E; Metzger R; Mönig SP
Cancer; 2010 Jan; 116(2):309-15. PubMed ID: 19950124
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II.
Park JM; Kim JH; Park SS; Kim SJ; Mok YJ; Kim CS
World J Surg; 2008 Jun; 32(6):1037-44. PubMed ID: 18347851
[TBL] [Abstract][Full Text] [Related]
27. Impact of spleen preservation in patients with gastric cancer.
Fatouros M; Roukos DH; Lorenz M; Arampatzis I; Hottentrott C; Encke A; Kappas AM
Anticancer Res; 2005; 25(4):3023-30. PubMed ID: 16080561
[TBL] [Abstract][Full Text] [Related]
28. Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system.
Bouliaris K; Rachiotis G; Diamantis A; Christodoulidis G; Polychronopoulou E; Tepetes K
Eur J Surg Oncol; 2017 Jul; 43(7):1350-1356. PubMed ID: 28433495
[TBL] [Abstract][Full Text] [Related]
29. Lymph node ratio is an independent prognostic factor in gastric cancer after curative resection (R0) regardless of the examined number of lymph nodes.
Alatengbaolide ; Lin D; Li Y; Xu H; Chen J; Wang B; Liu C; Lu P
Am J Clin Oncol; 2013 Aug; 36(4):325-30. PubMed ID: 22547011
[TBL] [Abstract][Full Text] [Related]
30. Current status and future perspectives in gastric cancer management.
Roukos DH
Cancer Treat Rev; 2000 Aug; 26(4):243-55. PubMed ID: 10913380
[TBL] [Abstract][Full Text] [Related]
31. Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: twenty years experience in Taiwan.
Lee WJ; Lee WC; Houng SJ; Shun CT; Houng RL; Lee PH; Chang KJ; Wei TC; Chen KM
World J Surg; 1995; 19(5):707-13. PubMed ID: 7571667
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for lymph node metastases and their prognostic significance in early gastric cancer (EGC) for the Italian Research Group for Gastric Cancer (IRGGC).
Folli S; Morgagni P; Roviello F; De Manzoni G; Marrelli D; Saragoni L; Di Leo A; Gaudio M; Nanni O; Carli A; Cordiano C; Dell'Amore D; Vio A;
Jpn J Clin Oncol; 2001 Oct; 31(10):495-9. PubMed ID: 11696619
[TBL] [Abstract][Full Text] [Related]
33. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
34. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.
Hartgrink HH; van de Velde CJ; Putter H; Bonenkamp JJ; Klein Kranenbarg E; Songun I; Welvaart K; van Krieken JH; Meijer S; Plukker JT; van Elk PJ; Obertop H; Gouma DJ; van Lanschot JJ; Taat CW; de Graaf PW; von Meyenfeldt MF; Tilanus H; Sasako M
J Clin Oncol; 2004 Jun; 22(11):2069-77. PubMed ID: 15082726
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of metastatic lymph nodes ratio in patients with gastric adenocarcinoma after curative gastrectomy.
Zhang M; Wang J; Shi W; Chen W; Li W; Shu Y; Liu P; Lu K
Chin Med J (Engl); 2014; 127(10):1874-8. PubMed ID: 24824248
[TBL] [Abstract][Full Text] [Related]
36. Quality control of lymph node dissection in the Dutch Gastric Cancer Trial.
de Steur WO; Hartgrink HH; Dikken JL; Putter H; van de Velde CJ
Br J Surg; 2015 Oct; 102(11):1388-93. PubMed ID: 26313463
[TBL] [Abstract][Full Text] [Related]
37. Long-term survival is improved by an extended lymph node dissection in potentially curable gastric cancer.
Reis E; Kama NA; Doganay M; Atli M; Dolapci M
Hepatogastroenterology; 2002; 49(46):1167-71. PubMed ID: 12143228
[TBL] [Abstract][Full Text] [Related]
38. Perigastric lymph node status can be a simple prognostic parameter in patients with gastric cancer.
Kim TH; Han SU; Cho YK; Kim MW
Hepatogastroenterology; 2000; 47(35):1475-8. PubMed ID: 11100380
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of splenectomy on advanced proximal gastric cancer with No. 10 lymph node metastasis.
Huang CM; Wang JB; Lu HS; Zheng CH; Li P; Xie JW; Zhang XF
Chin Med J (Engl); 2009 Nov; 122(22):2757-62. PubMed ID: 19951610
[TBL] [Abstract][Full Text] [Related]
40. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
